To confirm whether these nucleotide metabolites that were upregulated in metformin-treated H460 cells but down-regulated in metformin-treated Axin1-/- H460 cells, were involved in metformin-induced anti-tumor immunity, we first examined the production of ADP upon metformin treatment. The gene discussed is AXIN1; the disease is neoplasm.